Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical RGL-2102 for Diabetic Foot Ulcers
ChiCTR2500113376Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial of RGL-2102 in diabetic foot ulcer (DFU) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Proportion of wounds with complete healing. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
RGL-2102
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR2500113376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113376.